Document Detail


Detection of rifampicin-induced nephrotoxicity by N-acetyl-3-D-glucosaminidase activity.
MedLine Citation:
PMID:  1460703     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The objective of the present study was to assess renal damage, if any, by non-invasive technique, viz NAG activity in urine and GFR in patients on continuous and intermittent rifampicin therapy. Eighty-four tuberculosis patients for cross-sectional study and six subjects for longitudinal study on antitubercular therapy and ten patients on withdrawal of rifampicin participated in the investigation; 13 leprosy patients intermittently treated with rifampicin were also included. Twenty-seven normal subjects served as controls. Rifampicin on continuous use resulted in a progressive increase in enzymuria with no change in GFR. An additive toxic effect was obvious in patients receiving streptomycin; when the treatment was withdrawn the urinary NAG activity stabilized within 15-21 days. However, patients receiving rifampicin intermittently did not show any evidence of renal damage. The results suggest that there is a need for monitoring renal damage, particularly on antitubercular therapy, when nephrotoxic agents are administered together.
Authors:
B D Kumar; C E Prasad; K Krishnaswamy
Related Documents :
16636583 - Clinicopathological characteristics and outcome of adult patients with hematuria and/or...
11985133 - Cardiovascular disease and the kidney. tracking a killer in chronic kidney disease.
17090953 - Influence of l-thyroxine administration on poor-platelet plasma vegf concentrations in ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of tropical medicine and hygiene     Volume:  95     ISSN:  0022-5304     ISO Abbreviation:  J Trop Med Hyg     Publication Date:  1992 Dec 
Date Detail:
Created Date:  1993-01-13     Completed Date:  1993-01-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0406044     Medline TA:  J Trop Med Hyg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  424-7     Citation Subset:  IM    
Affiliation:
Food and Drug Toxicology Research Centre, National Institute of Nutrition, Hyderabad, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylglucosaminidase / urine*
Adult
Cross-Sectional Studies
Drug Synergism
Drug Therapy, Combination / adverse effects,  therapeutic use
Glomerular Filtration Rate
Humans
Kidney / drug effects*,  enzymology,  physiology
Leprosy / drug therapy
Middle Aged
Prospective Studies
Rifampin / adverse effects*,  therapeutic use
Streptomycin / adverse effects,  therapeutic use
Tuberculosis, Pulmonary / drug therapy
Chemical
Reg. No./Substance:
13292-46-1/Rifampin; 57-92-1/Streptomycin; EC 3.2.1.52/Acetylglucosaminidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of plastering in a house persistently infested with Triatoma infestans (Klug) 1934.
Next Document:  Magnetic resonance angiography of peripheral runoff vessels.